Kura Oncology presents at BofA conference

Kura Oncology presents at BofA conference
Kura Oncology, Inc. presented at the Bank of America Global Healthcare Conference on May 13, 2026, with Chairman and CEO Troy Wilson leading the discussion. The company showcased its latest developments in oncology research and pipeline progress to institutional investors and healthcare industry participants. Such presentations at major financial conferences typically signal management confidence in upcoming catalysts and provide opportunities for investor engagement on clinical progress and strategic direction. Healthcare conferences remain critical venues where biotech and pharmaceutical companies communicate their value propositions to the investment community.